Tags

Type your tag names separated by a space and hit enter

Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients.
Ren Fail. 2008; 30(1):57-62.RF

Abstract

BACKGROUND

Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients.

METHODS

We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education.

RESULTS

Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 +/- 1.33; post-education: 5.85 +/- 1.20 mg/dL, p < 0.001) and Ca x P product (pre-education: 68.17 +/- 12.70; post-education: 54.70 +/- 11.87 mg(2)/dL(2), p < 0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 +/- 277.6; non-improved: 668.0 +/- 674.1 ng/mL, p = 0.021).

CONCLUSIONS

Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.

Authors+Show Affiliations

School of Medicine, Chang Gung University, Taoyuan, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18197544

Citation

Sun, Chiao-Yin, et al. "Patient Education: an Efficient Adjuvant Therapy for Hyperphosphatemia in Hemodialysis Patients." Renal Failure, vol. 30, no. 1, 2008, pp. 57-62.
Sun CY, Chang KC, Chen SH, et al. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. Ren Fail. 2008;30(1):57-62.
Sun, C. Y., Chang, K. C., Chen, S. H., Chang, C. T., & Wu, M. S. (2008). Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. Renal Failure, 30(1), 57-62. https://doi.org/10.1080/08860220701742047
Sun CY, et al. Patient Education: an Efficient Adjuvant Therapy for Hyperphosphatemia in Hemodialysis Patients. Ren Fail. 2008;30(1):57-62. PubMed PMID: 18197544.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. AU - Sun,Chiao-Yin, AU - Chang,Kuo-Chuan, AU - Chen,Sue-Hsien, AU - Chang,Chiz-Tzung, AU - Wu,Mai-Szu, PY - 2008/1/17/pubmed PY - 2008/5/3/medline PY - 2008/1/17/entrez SP - 57 EP - 62 JF - Renal failure JO - Ren Fail VL - 30 IS - 1 N2 - BACKGROUND: Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. METHODS: We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. RESULTS: Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 +/- 1.33; post-education: 5.85 +/- 1.20 mg/dL, p < 0.001) and Ca x P product (pre-education: 68.17 +/- 12.70; post-education: 54.70 +/- 11.87 mg(2)/dL(2), p < 0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 +/- 277.6; non-improved: 668.0 +/- 674.1 ng/mL, p = 0.021). CONCLUSIONS: Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high. SN - 0886-022X UR - https://www.unboundmedicine.com/medline/citation/18197544/Patient_education:_an_efficient_adjuvant_therapy_for_hyperphosphatemia_in_hemodialysis_patients_ DB - PRIME DP - Unbound Medicine ER -